AC Immune Ltd
Biotechnology
Healthcare
ACIU
101 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.47
52 week high
4.77
high
1.60
52 week low
1.51
low
1.43
growth
-67.10 %
previous Close
1.51
P/E ratio
market cap
265 M
div yield
0
usd
Sep 2024
qoq
revenue
25.49 M
3.00 %
net incoming
5.50 M
124.18 %
eps
0.00 %
126.09 %
eps surprise
126.09 %
net profit margin
21.59 %
3334.00 %
operating incoming
7.27 M
134.68 %
net change in cash
-19.15 M
-571.59 %
cash on hand
32.42 M
-37.13 %
cost of revenue
0.00 %
top top